(Q85404993)
English
Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of mainte
scientific article published on 02 November 2012
Statements
Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance (English)
Richard Sylvester
Maurizio Brausi
Aldo Bono
Cees van de Beek
George van Andel
Wolfgang Hoeltl
Levent Turkeri
Sandrine Marreaud
Sandra Collette
Willem Oosterlinck
2 November 2012